{"id":10249,"date":"2019-10-04T07:24:55","date_gmt":"2019-10-04T11:24:55","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=10249"},"modified":"2019-10-04T07:24:55","modified_gmt":"2019-10-04T11:24:55","slug":"new-filings-updated-terms-ending-10-4-19am","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/new-filings-updated-terms-ending-10-4-19am\/","title":{"rendered":"New Filings &#038; Updated Terms (ending 10.4.19am)"},"content":{"rendered":"<p><!--more--><br \/>\n<span style=\"text-decoration: underline;\"><strong>NEW FILINGS<\/strong><\/span><\/p>\n<p>Company: Progyny, Inc.<br \/>\nSymbol: PGNY<br \/>\nDescription: They envision a world where anyone who wants to have a child can do so. Our mission is to make dreams of parenthood come true through healthy, timely and supported fertility journeys.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): J.P. Morgan, Goldman Sachs &amp; Co, BofA Merrill Lynch, Citigroup<br \/>\nCo-Manager: Piper Jaffray, SVB Leerink, TPG Capital<br \/>\nFiled: 9-27-19<br \/>\nListed Cash Raise: $100m<\/p>\n<p>Company: Beam Therapeutics, Inc.<br \/>\nSymbol: BEAM<br \/>\nDescription: They are a biotechnology company committed to creating a new class of precision genetic medicines based on our proprietary base editing technology, with a vision of providing life-long cures to patients suffering from serious diseases.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): JP Morgan, Jefferies, Barclays<br \/>\nCo-Manager: Wedbush PacGrow<br \/>\nFiled: 9-27-19<br \/>\nListed Cash Raise: $100m<\/p>\n<p>Company: Youdao, Inc<br \/>\nSymbol: DAO<br \/>\nDescription: For over a decade, Youdao has developed and used technologies to provide learning content, applications and solutions to users of all ages.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): Citigroup, Morgan Stanley, CICC, HSBC<br \/>\nFiled: 9-30-19<br \/>\nListed Cash Raise: $300m<\/p>\n<p>Company: 36Kr Holdings Inc.<br \/>\nSymbol: TBD<br \/>\nDescription: They are a prominent brand and a pioneering platform dedicated to serving New Economy participants in China.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): Credit Suisse, CICC<br \/>\nFiled: 9-30-19<br \/>\nListed Cash Raise: $100m<\/p>\n<p>Company: Fortis Minerals LLC<br \/>\nSymbol: NRI<br \/>\nDescription: They are a returns-focused company formed to pursue oil and natural gas mineral and royalty interest opportunities in leading oil-weighted onshore domestic resource plays.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): Credit Suisse, Goldman Sachs &amp; Co, Barclays Citigroup, J.P. Morgan, RBC Capital Markets, Scotia Howard Weil, UBS Investment Bank, Wells Fargo Securities<br \/>\nCo-Manager: Raymond James, Simmons Energy, Tudor Pickering Holt &amp; Co.<br \/>\nFiled: 9-30-19<br \/>\nListed Cash Raise: $100m<\/p>\n<p>Company: Aesthetic Medical International Holdings Group Limited<br \/>\nSymbol: AIH<br \/>\nDescription: They are a leading provider of aesthetic medical services in China.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): Cantor, Haitong International<br \/>\nCo-Manager: Prime Number Capital, Maxim Group, CMBI, Zinvest Global<br \/>\nFiled: 9-30-19<br \/>\nListed Cash Raise: $80m<\/p>\n<p>Company: 4D Molecular Therapeutics, Inc.<br \/>\nSymbol: DDDD<br \/>\nDescription: They are a development stage precision gene therapy company dedicated to pioneering the development of targeted therapies based on our next-generation AAV vectors.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): Goldman Sachs, Evercore ISI, William Blair<br \/>\nCo-Manager: Chardan<br \/>\nFiled: 9-30-19<br \/>\nListed Cash Raise: $100m<\/p>\n<p>Company: Phathom Pharmaceuticals, Inc.<br \/>\nSymbol: PHAT<br \/>\nDescription: They are a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): Goldman Sachs, Jefferies, Evercore ISI<br \/>\nCo-Manager: Needham &amp; Co.<br \/>\nFiled: 9-30-19<br \/>\nListed Cash Raise: $100m<\/p>\n<p>Company: Cabaletta Bio, Inc.<br \/>\nSymbol: CABA<br \/>\nDescription: They are a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): Morgan Stanley, Cowen, Evercore ISI<br \/>\nFiled: 9-30-19<br \/>\nListed Cash Raise: $100m<\/p>\n<p><span style=\"text-decoration: underline;\"><strong>TERMS ADDED<\/strong><\/span><\/p>\n<p>Company: Vir Biotechnology, Inc.<br \/>\nSymbol: VIR<br \/>\nDescription: They are a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases.<br \/>\nShares: 7.1 million<br \/>\nPrice Range: $20.00-$22.00<br \/>\nMarket Cap: $2.2b-$2.42b<br \/>\nTrade Date: Friday, 10\/11<br \/>\nUnderwriter(s): Goldman Sachs, JP Morgan, Cowen, Barclays<br \/>\nTerms Added: 9-30-19<\/p>\n<p>Company: Karat Packaging Inc.<br \/>\nSymbol: KRAT<br \/>\nDescription: They are a rapidly-growing manufacturer and distributor of environmentally-friendly, single-use disposable products primarily used in restaurants and foodservice settings.<br \/>\nShares: 5 million<br \/>\nPrice Range: $7.00-$9.00<br \/>\nMarket Cap: $140m-$181m<br \/>\nTrade Date: Wk of 10\/14<br \/>\nUnderwriter(s): National Securities<br \/>\nCo-Manager: Loop Capital Markets LLC<br \/>\nTerms Added: 9-30-19<\/p>\n<p>Company: HBT Financial, Inc.<br \/>\nSymbol: HBT<br \/>\nDescription: They are HBT Financial, Inc. (formerly known as Heartland Bancorp, Inc.), a bank holding company headquartered in Bloomington, Illinois.<br \/>\nShares: 8.3 million<br \/>\nPrice Range: $17.00-$19.00<br \/>\nMarket Cap: $450m-$500m<br \/>\nTrade Date: Friday, 10\/11<br \/>\nUnderwriter(s): Keefe Bruyette &amp; Woods, J.P. Morgan<br \/>\nTerms Added: 10-1-19<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24,1536],"tags":[],"class_list":["post-10249","post","type-post","status-publish","format-standard","hentry","category-ipo","category-subscriber-content"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/10249","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=10249"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/10249\/revisions"}],"predecessor-version":[{"id":10250,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/10249\/revisions\/10250"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=10249"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=10249"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=10249"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}